pixantrone has been researched along with Sarcoma 180 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Deng, Y; Hu, L; Jia, X; Li, C; Liu, M; Liu, X; Liu, Y; Lu, M; Luo, X; McClements, DJ; Qiu, Q; Song, Y; Zhang, T; Zhou, S | 1 |
1 other study(ies) available for pixantrone and Sarcoma 180
Article | Year |
---|---|
Targeted delivery of pixantrone to neutrophils by poly(sialic acid)-p-octadecylamine conjugate modified liposomes with improved antitumor activity.
Topics: Amines; Animals; Antineoplastic Agents; Cell Line, Tumor; Chemistry, Pharmaceutical; Drug Carriers; Drug Delivery Systems; Isoquinolines; Liposomes; Male; Mice; N-Acetylneuraminic Acid; Neutrophils; Particle Size; Rats; Rats, Wistar; Sarcoma 180; Tumor Microenvironment; Xenograft Model Antitumor Assays | 2018 |